Related Experiment Videos
The effect of sodium warfarin on rabbit monocyte tissue factor expression
Thrombosis Research
|April 15, 1986
Summary
Sodium warfarin significantly impairs monocyte tissue factor (MTF) activity in rabbits, an effect reversed by Vitamin K. This suggests warfarin may inhibit cell-mediated coagulation by affecting factor VII binding to monocytes.
Area of Science:
- Hematology
- Pharmacology
Background:
- Monocyte tissue factor (MTF) plays a crucial role in initiating the coagulation cascade.
- Warfarin is a widely used anticoagulant, but its precise mechanisms of action on cellular components are not fully elucidated.
Purpose of the Study:
- To investigate the impact of sodium warfarin on peripheral blood monocyte tissue factor (MTF) activity in a rabbit model.
- To explore the role of Vitamin K and potential plasma factors in mediating warfarin's effects on MTF.
Main Methods:
- Induction of a rabbit model for studying MTF activity.
- Treatment with sodium warfarin and subsequent assessment of MTF expression.
- Investigating the reversal effect of Vitamin K.
- Culturing monocytes in plasma from warfarin-treated and normal rabbits.
Main Results:
- Sodium warfarin significantly inhibited MTF expression after three days of treatment (p < 0.003).
- Vitamin K effectively reversed warfarin-induced MTF inhibition.
- Warfarin-resistant animals showed no anticoagulation or MTF inhibition.
- Monocytes cultured in plasma from warfarin-treated rabbits exhibited reduced MTF activity.
Conclusions:
- Warfarin treatment impairs monocyte tissue factor activity.
- Vitamin K can reverse this inhibition, highlighting its role in counteracting warfarin's effects.
- A plasma component, potentially abnormal factor VII, may bind to monocytes and inhibit MTF activity, representing a novel mechanism for warfarin's anticoagulant action.